Nalaganje...
Multiple testing of treatment-effect modifying biomarkers in a randomized clinical trial with a survival endpoint
The recent revolution in genomics and the advent of targeted therapies have increased interest in biomarker-defined subgroups of patients who respond to therapy or exhibit specific toxicities. Such biomarker-defined subgroups are also being investigated for non-targeted therapies (e.g. chemotherapy...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2011
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3098305/ https://ncbi.nlm.nih.gov/pubmed/21344471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.4022 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|